Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Study sponsor: OPKO Health, Inc. · OPK
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2021-02-24Actual
Enrollment · participants44Actual
Source updated2026-04-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.